ストックスクリーナーアプリを入手
7.37
0.67%
-0.05
アフターアワーズ：
7.38
0.010
+0.14%
前日終値:
$7.42
開ける：
$7.47
24時間の取引高:
70,879
Relative Volume:
0.37
時価総額：
$275.70M
収益：
$128.45M
当期純損益:
$6.54M
株価収益率:
147.40
EPS:
0.05
ネットキャッシュフロー:
$-8.79M
1週間 パフォーマンス:
+1.80%
1か月 パフォーマンス:
-4.16%
6か月 パフォーマンス:
+21.02%
1年 パフォーマンス:
+23.24%
1日の値動き範囲:
$7.185
$7.47
1週間の範囲:
$7.03
$7.8651
52週間の値動き範囲:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
LFCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.37 | 277.57M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-21 | 開始されました | William Blair | Outperform |
| 2024-09-05 | 開始されました | Craig Hallum | Buy |
| 2024-08-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | ダウングレード | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc (LFCR) 最新ニュース
Technical analysis overview for Lifecore Biomedical Inc. stockJuly 2025 Closing Moves & High Yield Stock Recommendations - Newser
Tools to monitor Lifecore Biomedical Inc. recovery probabilityWeekly Trade Report & AI Enhanced Market Trend Forecasts - Newser
Signal strength of Lifecore Biomedical Inc. stock in tech scanners2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
Lifecore Biomedical Inc. stock chart pattern explained2025 Technical Overview & High Accuracy Swing Entry Alerts - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.July 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
Analyzing Lifecore Biomedical Inc. with multi timeframe chartsWeekly Trend Recap & Daily Oversold Bounce Ideas - Newser
Should you hold or exit Lifecore Biomedical Inc. nowTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Is Lifecore Biomedical Inc. forming a bullish divergenceStock Surge & Technical Pattern Based Buy Signals - thegnnews.com
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsBond Market & Long-Term Safe Investment Plans - Newser
Is Lifecore Biomedical Inc. the Top Chart Pick This WeekJuly 2025 Selloffs & Free Long-Term Investment Growth Plans - newsyoung.net
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - ACCESS Newswire
Sector Rotation Brings Lifecore Biomedical Inc. Into FocusGap Down & Safe Swing Trade Setups - newsyoung.net
XTX Topco Ltd Takes $145,000 Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Is Lifecore Biomedical Inc. stock a good hedge against inflation2025 Price Momentum & Breakout Confirmation Alerts - Newser
Volume spikes in Lifecore Biomedical Inc. stock – what they meanWeekly Growth Portfolio Performance Summary - Newser
What to expect from Lifecore Biomedical Inc. in the next 30 daysFree Entry Alert With Low Drawdown Strategy - Newser
Short interest data insights for Lifecore Biomedical Inc.Quarterly Investment Outlook and Key Summary - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsTechnical Insight Guide for Safer Trades - Newser
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - MSN
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingPredictable Return Strategy with AI Support - Newser
Lifecore Biomedical Exceeds Revenue Estimates, Reports Q4 $36.4M and EPS Loss of $0.06 - AInvest
Lifecore Biomedical Inc. Attempts Reversal From Key SupportAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Lifecore Biomedical 2025 Q4 Earnings Significant Net Loss Improvement - AInvest
Lifecore (LFCR) Q4 Revenue Beats 3% - AOL.com
Lifecore Biomedical shares fall 3.61% intraday despite reporting $128.9 million in fiscal 2025 revenue. - AInvest
Lifecore Biomedical: Navigating Headwinds with Strategic Resilience and Long-Term Growth Catalysts - AInvest
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth - AInvest
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing - simplywall.st
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss - Investing.com Nigeria
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Lifecore Biomedical: Fiscal Q4 Earnings Snapshot - Connecticut Post
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : Lifecore Biomedical, Inc., Q4 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Lifecore Biomedical’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Lifecore Biomedical earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Lifecore Biomedical reports $128.9mln FY25 revenue, meets full-year guidance. - AInvest
Lifecore Biomedical Reports Q4 and FY25 Financial Results, Achieves Full-Year Guidance, and Provides Corporate Update - AInvest
Laughing Water Capital's Top 5 Holdings for Q2 2025 - AInvest
Lifecore Biomedical Inc (LFCR) 財務データ
収益
当期純利益
現金流量
EPS
2.80%
0.22%
大文字化:
|
ボリューム (24 時間):